Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 9/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6943135 | 1.00 | HCAR2 (0.41) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL6943131 | 0.92 | KEAP1 (0.31) | HCAR2 | |
| SCHEMBL27724490 | 0.76 | HCAR2 (0.37) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL8172217 | 0.65 | — | — | |
| SCHEMBL18784689 | 0.63 | HCAR2 (0.55) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL18784690 | 0.63 | HCAR2 (0.55) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL20673701 | 0.63 | — | — | |
| SCHEMBL7060098 | 0.63 | — | — | |
| SCHEMBL1979606 | 0.62 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL8978208 | 0.62 | HCAR2 (0.60) | HCAR2TSHRTP53EGLN1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030039580-A1 | Stable preservative formulations comprising halopropynyl compounds and butoxydiglycol solvent | LONZA INC. (US) | 2003-02-27 | — | — | US | claimed |
| WO-2002067685-A1 | STABLE PRESERVATIVE FORMULATIONS COMPRISING HALOPROPYNYL COMPOUNDS AND BUTOXYDIGLYCOL SOLVENT | LONZA INC. (US) | 2002-09-06 | — | — | WO | claimed |
| EP-1022950-B1 | STABILISED MIXTURES OF AN IODOPROPARGYL COMPOUND AND A FORMALDEHYDE DONOR | LONZA AG (US) | 2003-08-20 | — | — | EP | disclosed |
| US-6582627-B1 | Aqueous liquid, broad-spectrum, low free-formaldehyde synergistic preservative mixtures of an iodopropynyl compound and a formaldehyde donor | LONZA INC. | 2003-06-24 | — | — | US | disclosed |
| US-20030039580-A1 | Stable preservative formulations comprising halopropynyl compounds and butoxydiglycol solvent | LONZA INC. (US) | 2003-02-27 | — | — | US | disclosed |
| WO-2002067685-A1 | STABLE PRESERVATIVE FORMULATIONS COMPRISING HALOPROPYNYL COMPOUNDS AND BUTOXYDIGLYCOL SOLVENT | LONZA INC. (US) | 2002-09-06 | — | — | WO | disclosed |
| US-6143204-A | STABILIZED IODOPROPYNYL SOLUTION CONSISTS OF AN IODOPROPYNYL COMPOUND AND A STABILIZER WHICH IS HYDANTOIN OR DERIVATIVE | LONZA INC. (US) | 2000-11-07 | — | — | US | disclosed |
| EP-1022950-A1 | STABILISED MIXTURES OF AN IODOPROPARGYL COMPOUND AND A FORMALDEHYDE DONOR | LONZA INC. (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999065316-A9 | STABILIZED MIXTURES OF AN IODOPROPARGYL COMPOUND AND A FORMALDEHYDE DONOR | LONZA AG (US) | 2000-03-23 | — | — | WO | disclosed |
| WO-1999065316-A1 | STABILIZED MIXTURES OF AN IODOPROPARGYL COMPOUND AND A FORMALDEHYDE DONOR | LONZA INC. (US) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030039580-A1 | Stable preservative formulations comprising halopropynyl compounds and butoxydiglycol solvent | DDC, HDHD5, GMDS | HCAR2 2085/4885TSHR 3963/4885TP53 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.